Automation is key to saving lives
Personalized tumour treatments are expensive. This particularly applies to individual cancer therapies based on gene-modified T cells. Currently, they are produced manually or, at best, in a partially automated process. In a collaboration project “ProCell for Patient” two hospitals are currently working with Optima Pharma to develop an automated unit for the decentralized production of […]
